Probiotics in the Prevention and Treatment of Necrotizing Enterocolitis

키워드

참고문헌 (57)

1. Bellodas Sanchez J, "Necrotizing enterocolitis", Neurogastroenterol Motil, 31, pp.e13569~ (2019)
2. Battersby C, "Incidence and enteral feed antecedents of severe neonatal necrotising enterocolitis across neonatal networks in England, 2012-13: a whole-population surveillance study", Lancet Gastroenterol Hepatol, 2, pp.43~51 (2017)
3. Boccia D, "Nosocomial necrotising enterocolitis outbreaks : epidemiology and control measures", Eur J Pediatr, 160, pp.385~391 (2001)
4. Samuels N, "Risk factors for necrotizing enterocolitis in neonates : a systematic review of prognostic studies", BMC Pediatr, 17, pp.105~ (2017)
5. Kuppala VS, "Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants", J Pediatr, 159, pp.720~725 (2011)
6. Carrion V, "Prevention of neonatal necrotizing enterocolitis", J Pediatr Gastroenterol Nutr, 11, pp.317~323 (1990)
7. Gray KD, "Probiotic use and safety in the neonatal intensive care unit : a matched cohort study", J Pediatr, 222, pp.59~64 (2020)
8. Chandran S, "Evidence-based practices reduce necrotizing enterocolitis and improve nutrition outcomes in very low-birth-weight infants", JPEN J Parenter Enteral Nutr (2020)[DOI]
9. Sharif S, "Probiotics to prevent necrotising enterocolitis in very preterm or very low birth weight infants", Cochrane Database Syst Rev, 10, pp.CD005496~ (2020)
10. Underwood MA, "Bifidobacterium longum subspecies infantis : champion colonizer of the infant gut", Pediatr Res, 77, pp.229~235 (2015)
11. Underwood MA, "Probiotics and the prevention of necrotizing enterocolitis", J Pediatr Surg, 54, pp.405~412 (2019)
12. Pammi M, "Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis : a systematic review and meta-analysis", Microbiome, 5, pp.31~ (2017)
13. McMurtry VE, "Bacterial diversity and Clostridia abundance decrease with increasing severity of necrotizing enterocolitis", Microbiome, 3, pp.11~ (2015)
14. Jangi S, "Asymptomatic colonization by Clostridium difficile in infants : implications for disease in later life", J Pediatr Gastroenterol Nutr, 51, pp.2~7 (2010)
15. Wilson KH, "Antagonism of toxigenic Clostridium difficile by nontoxigenic C. difficile", J Infect Dis, 147, pp.733~736 (1983)
16. Meier PP, "Evidence-based methods that promote human milk feeding of preterm infants : an expert review", Clin Perinatol, 44, pp.1~22 (2017)
17. Yu Y, "Maternal administration of probiotics promotes gut development in mouse offsprings", PLoS One, 15, pp.e0237182~ (2020)
18. Sodhi CP, "Intestinal epithelial Toll-like receptor 4 regulates goblet cell development and is required for necrotizing enterocolitis in mice", Gastroenterology, 143, pp.708~718 (2012)
19. Hackam DJ, "New insights into necrotizing enterocolitis : from laboratory observation to personalized prevention and treatment", J Pediatr Surg, 54, pp.398~404 (2019)
20. Peng L, "Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers", J Nutr, 139, pp.1619~1625 (2009)
21. Newburg DS, "Human milk glycans protect infants against enteric pathogens", Annu Rev Nutr, 25, pp.37~58 (2005)
22. Herrmann K, "An exclusively human milk diet reduces necrotizing enterocolitis", Breastfeed Med, 9, pp.184~190 (2014)
23. Dvorak B, "Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model", Am J Physiol Gastrointest Liver Physiol, 282, pp.G156~G164 (2002)
24. Good M, "Breast milk protects against the development of necrotizing enterocolitis through inhibition of Toll-like receptor 4 in the intestinal epithelium via activation of the epidermal growth factor receptor", Mucosal Immunol, 8, pp.1166~1179 (2015)
25. Good M, "Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium", Proc Natl Acad Sci U S A, 109, pp.11330~11335 (2012)
26. Gribar SC, "Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis", J Immunol, 182, pp.636~646 (2009)
27. Lu P, "Toll-like receptor regulation of intestinal development and inflammation in the pathogenesis of necrotizing enterocolitis", Pathophysiology, 21, pp.81~93 (2014)
28. Mathipa MG, "Probiotic engineering : towards development of robust probiotic strains with enhanced functional properties and for targeted control of enteric pathogens", Gut Pathog, 9, pp.28~ (2017)
29. Kumar A, "The bacterial fermentation product butyrate influences epithelial signaling via reactive oxygen species-mediated changes in cullin-1 neddylation", J Immunol, 182, pp.538~546 (2009)
30. Rivera-Chávez F, "Oxygen as a driver of gut dysbiosis", Free Radic Biol Med, 105, pp.93~101 (2017)
31. Patel RM, "Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function", Am J Pathol, 180, pp.626~635 (2012)
32. Martinez FA, "Bacteriocin production by Bifidobacterium spp. A review", Biotechnol Adv, 31, pp.482~488 (2013)
33. Hoyos AB, "Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit", Int J Infect Dis, 3, pp.197~202 (1999)
34. Sawh SC, "Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis", PeerJ, 4, pp.e2429~ (2016)
35. Patel RM, "Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?", Clin Perinatol, 40, pp.11~25 (2013)
36. Jacobs SE, "Probiotic effects on late-onset sepsis in very preterm infants : a randomized controlled trial", Pediatrics, 132, pp.1055~1062 (2013)
37. Costeloe K, "A randomised controlled trial of the probiotic Bifidobacterium breve BBG-001 in preterm babies to prevent sepsis, necrotising enterocolitis and death: the Probiotics in Preterm infantS (PiPS) trial", Health Technol Assess, 20, pp.1~94 (2016)
38. Zozaya C, "Incidence, treatment, and outcome trends of necrotizing enterocolitis in preterm infants: a multicenter cohort study", Front Pediatr, 8, pp.188~ (2020)
39. van den Akker CHP, "Probiotics and preterm infants : a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics", J Pediatr Gastroenterol Nutr, 70, pp.664~680 (2020)
40. Chi C, "Effects of probiotics in preterm infants: a network metaanalysis", Pediatrics, 147, pp.e20200706~ (2021)
41. Morgan RL, "Probiotics reduce mortality and morbidity in preterm, low-birth-weight infants: a systematic review and network meta-analysis of randomized trials", Gastroenterology, 159, pp.467~480 (2020)
42. Dani C, "Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review", AJP Rep, 6, pp.e25~e29 (2016)
43. Yelin I, "Genomic and epidemiological evidence of bacterial transmission from probiotic capsule to blood in ICU patients", Nat Med, 25, pp.1728~1732 (2019)
44. Mack DR., "D(-)-lactic acid-producing probiotics, D(-)-lactic acidosis and infants", Can J Gastroenterol, 18, pp.671~675 (2004)
45. Papagaroufalis K, "A randomized double blind controlled safety trial evaluating d-lactic acid production in healthy infants fed a Lactobacillus reuteri-containing formula", Nutr Metab Insights, 7, pp.19~27 (2014)
46. Reddy VS, "Role of probiotics in short bowel syndrome in infants and children--a systematic review", Nutrients, 5, pp.679~699 (2013)
47. Munakata S, "A case of D-lactic acid encephalopathy associated with use of probiotics", Brain Dev, 32, pp.691~694 (2010)
48. "Standard for infant formula and formulas for special medical purposes intended for infants" (2016)[URL]
49. Lewis ZT, "Validating bifidobacterial species and subspecies identity in commercial probiotic products", Pediatr Res, 79, pp.445~452 (2016)
50. de Simone C, "The unregulated probiotic market", Clin Gastroenterol Hepatol, 17, pp.809~817 (2019)
51. Akar M, "Impact of oral probiotics on neurodevelopmental outcomes in preterm infants", J Matern Fetal Neonatal Med, 30, pp.411~415 (2017)
52. Garland SM, "The ProPrems trial : investigating the effects of probiotics on late onset sepsis in very preterm infants", BMC Infect Dis, 11, pp.210~ (2011)
53. Guthmann F, "Probiotics for prevention of necrotising enterocolitis : an updated meta-analysis", Klin Padiatr, 222, pp.284~290 (2010)
54. Adams M, "Preventive strategies and factors associated with surgically treated necrotising enterocolitis in extremely preterm infants: an international unit survey linked with retrospective cohort data analysis", BMJ Open, 9, pp.e031086~ (2019)
55. Bertazzoni E, "Probiotics and clinical effects: is the number what counts?", J Chemother, 25, pp.193~212 (2013)
56. Craighead AF, "Cost-effectiveness of probiotics for necrotizing enterocolitis prevention in very low birth weight infants", J Perinatol, 40, pp.1652~1661 (2020)
57. Fleming P, "Bifidobacterium breve BBG-001 and intestinal barrier function in preterm babies: exploratory studies from the PiPS trial", Pediatr Res (2020)[DOI]

관련 논문AI추천